Clinical Outcomes of a Genomic Screening Program for Actionable Genetic Conditions. Issue 4 (April 2021)

• Record Type: Journal Article
• Authors: Buchanan, Adam H.; Kirchner, H. Lester; Schwartz, Marci L. B.; Kelly, Melissa A.; Schmidlen, Tara; Jones, Laney K.; Hallquist, Miranda L. G.; Rocha, Heather; Betts, Megan; Schwiter, Rachel; Butry, Loren; Lazzeri, Amanda L.; Frisbie, Lauren R.; Rahm, Alanna Kulchak; Hao, Jing; Willard, Huntington F.; Martin, Christa L.; Ledbetter, David H.; Williams, Marc S.; Sturm, Amy C.
• Is Part Of: Obstetrical & gynecological survey. Volume 76:Issue 4(2021)
• Page Start: 193
• Page End: 194
• Publication Date: 2021-04
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Surgery -- Periodicals; 618
• DOI: 10.1097/01.ogx.0000743356.15320.79
• Languages: English
• ISSNs: 0029-7828

Abstract

Abstract : (Abstracted from Genet Med 2020;22:1874–1882) Hereditary breast and ovarian cancer (HBOC), Lynch syndrome, and familial hypercholesterolemia (FH) are recognized by the Centers of Disease Control and Prevention as tier-1 genetic conditions for which early identification and management could decrease morbidity and mortality. Yet few patients with a personal or familial history of these conditions are screened for genetic risk.